Synthesis of the octahydroindole core of aeruginosins: a new bicyclic α-amino acid
摘要:
The first synthesis of 6-hydroxyoctahydroindole-2-carboxylic acid derivatives with a cis fusion in the azabicyclic nucleus is described. The synthesis involves a Birch reduction of O-methyl-L-tyrosine followed by an aminocyclization in acid medium to give a mixture of 6-oxo-octahydroindole-2-carboxylic acids 3 and 4, which could be separated after dibenzylation. Transesterification, hydrogenolysis in the presence of acetic anhydride and reduction of the amido ketones 9 and 10 provides the four stereoisomeric alcohols from which alcohol 14 showed nmr data very close to the aeruginosin 298-A core. Copyright (C) 1996 Elsevier Science Ltd
[EN] [B]-FUSED BICYCLIC PROLINE DERIVATIVES AND THEIR USE FOR TREATING ARTHRITIC CONDITIONS [FR] DERIVES BICYCLIQUES [B]-FUSIONNES DE PROLINE ET LEUR UTILISATION POUR TRAITER DES ETATS ARTHRITIQUES
An optically active octahydroindole, the core unit of aeruginosins (Choi) was synthesized. The Diels–Alder reaction of Danishefsky's diene with methyl (Z)-2-acetamido-2,4-pentadienoates provided the adducts regioselectively in good yield. The adducts were converted to the l-Choi precursor by asymmetric hydrogenation, followed by acid cyclization.
First Total Syntheses of Aeruginosin 298-A and Aeruginosin 298-B, Based on a Stereocontrolled Route to the New Amino Acid 6-Hydroxyoctahydroindole-2-carboxylic Acid
The first total syntheses of aeruginosin 298-A (1) and aeruginosin 298-B (3) are described. The syntheses of the alternative putative structures 2 and 4 were also accomplished. The key common strategic element is the stereo-controlled synthesis of (2S,3aS,6R,7aS)-6-hydroxyoctahydroindole-2-carboxylic acid (L-Choi, 5) from L-tyrosine. The synthesis of this new bicyclic alpha-amino acid, which is the core
[B]-fused bicyclic proline derivatives and their use for treating arthritic conditions
申请人:Barvian C. Nicole
公开号:US20050143427A1
公开(公告)日:2005-06-30
This invention relates to a compound which is [b]-fused bicyclic proline derivative, or a pharmaceutically acceptable salt thereof; a pharmaceutical composition comprising the compound or the salt thereof, and methods of treating diseases, including, but not limited to, methods of preventing or inhibiting joint cartilage damage and preventing or treating diseases characterized by joint cartilage damage, joint inflammation, or joint pain. The [b]-fused bicyclic proline derivatives are compounds of Formula I as described above. Diseases characterized by joint cartilage damage or joint pain include, for example, osteoarthritis and rheumatoid arthritis. Rheumatoid arthritis is also characterized by joint inflammation. This invention also relates to methods of synthesizing and preparing the [b]-fused bicyclic proline derivatives, or a pharmaceutically acceptable salt thereof.
[EN] [B]-FUSED BICYCLIC PROLINE DERIVATIVES AND THEIR USE FOR TREATING ARTHRITIC CONDITIONS<br/>[FR] DERIVES BICYCLIQUES [B]-FUSIONNES DE PROLINE ET LEUR UTILISATION POUR TRAITER DES ETATS ARTHRITIQUES
申请人:WARNER LAMBERT CO
公开号:WO2004092132A1
公开(公告)日:2004-10-28
The invention relates to a compound which is [b]-fused bicyclic proline derivative, or a pharmaceutically acceptable salt thereof; a pharmaceutical composition comprising the compound or the salt thereof, and methods of treating diseases, including, but not limited to, methods of preventing or inhibiting joint cartilage damage and preventing or treating diseases characterized by joint cartilage damage, joint inflammation, or joint pain. The [b]-fused bicyclic proline derivatives are compounds of Formula I as described above. Diseases characterized by joint cartilage damage or joint pain include, for example, osteoarthritis and rheumatoid arthritis. Rheumatoid arthritis is also characterized by joint inflammation. This invention also relates to methods of synthesizing and preparing the [b]-fused bicyclic proline derivatives, or a pharmaceutically acceptable salt thereof.
The first synthesis of 6-hydroxyoctahydroindole-2-carboxylic acid derivatives with a cis fusion in the azabicyclic nucleus is described. The synthesis involves a Birch reduction of O-methyl-L-tyrosine followed by an aminocyclization in acid medium to give a mixture of 6-oxo-octahydroindole-2-carboxylic acids 3 and 4, which could be separated after dibenzylation. Transesterification, hydrogenolysis in the presence of acetic anhydride and reduction of the amido ketones 9 and 10 provides the four stereoisomeric alcohols from which alcohol 14 showed nmr data very close to the aeruginosin 298-A core. Copyright (C) 1996 Elsevier Science Ltd